14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 KZR stock ended at $0.86. This is 0.316% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.38% from a day low at $0.84 to a day high of $0.86.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Kezar Life Sciences Inc prices

Date Open High Low Close Volume
May 03, 2024 $0.86 $0.86 $0.84 $0.86 190 748
May 02, 2024 $0.84 $0.87 $0.83 $0.85 659 152
May 01, 2024 $0.83 $0.85 $0.82 $0.84 966 772
Apr 30, 2024 $0.84 $0.85 $0.82 $0.82 628 941
Apr 29, 2024 $0.82 $0.85 $0.81 $0.84 579 343
Apr 26, 2024 $0.80 $0.81 $0.780 $0.80 492 116
Apr 25, 2024 $0.80 $0.81 $0.773 $0.790 562 506
Apr 24, 2024 $0.81 $0.83 $0.80 $0.80 418 789
Apr 23, 2024 $0.81 $0.84 $0.81 $0.83 518 203
Apr 22, 2024 $0.80 $0.83 $0.785 $0.82 687 050
Apr 19, 2024 $0.780 $0.80 $0.771 $0.790 416 536
Apr 18, 2024 $0.82 $0.82 $0.785 $0.788 539 990
Apr 17, 2024 $0.80 $0.82 $0.772 $0.82 446 769
Apr 16, 2024 $0.82 $0.82 $0.772 $0.783 592 114
Apr 15, 2024 $0.86 $0.87 $0.80 $0.81 543 634
Apr 12, 2024 $0.86 $0.88 $0.85 $0.86 615 819
Apr 11, 2024 $0.80 $0.87 $0.80 $0.86 1 315 333
Apr 10, 2024 $0.81 $0.82 $0.791 $0.80 583 610
Apr 09, 2024 $0.80 $0.83 $0.80 $0.83 536 984
Apr 08, 2024 $0.80 $0.82 $0.790 $0.81 564 824
Apr 05, 2024 $0.82 $0.82 $0.750 $0.798 976 928
Apr 04, 2024 $0.84 $0.87 $0.81 $0.82 1 056 757
Apr 03, 2024 $0.86 $0.90 $0.84 $0.86 782 744
Apr 02, 2024 $0.89 $0.89 $0.85 $0.86 518 619
Apr 01, 2024 $0.91 $0.93 $0.86 $0.92 821 650
Click to get the best stock tips daily for free!

About Kezar Life Sciences Inc

Kezar Life Sciences Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b ... KZR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT